Drug intelligence / Profile preview

[3,5-dibromo-4-(4-hydroxy-3-phenethylcarbamoyl-phenoxy)-phenyl]-acetic acid

Development stage
Unknown
Lead developer
Los Alamos National Security
Modality
Small Molecules
01

Overview

[3,5-Dibromo-4-(4-Hydroxy-3‑Phenethylcarbamoyl‑Phenoxy)‑Phenyl]-Acetic Acid is a synthetic small molecule belonging to the class of brominated phenylacetic acids. It features a complex aromatic structure with dibrominated and carbamoylated phenolic groups. The compound is listed as an experimental molecule and has not been approved for any therapeutic use or clinical indication. There are no known clinical trials or marketed products containing this substance. Its mechanism of action and biological targets have not been characterized in the literature or major drug databases[1][2][3][6].

Other names
2-[3,5-dibromo-4-(4-hydroxy-3-{hydroxy[(2-phenylethyl)amino]methyl}phenoxy)phenyl]ethane-1,1-diol2-[3,5-dibromo-4-[4-hydroxy-3-(2-phenylethylcarbamoyl)phenoxy]phenyl]acetic acid(3,5-dibromo-4-(4-hydroxy-3-phenyethylcarbamoyl phenoxy)-phenyl)-acetic acid

Beyond the preview

Go deeper on [3,5-dibromo-4-(4-hydroxy-3-phenethylcarbamoyl-phenoxy)-phenyl]-acetic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on [3,5-dibromo-4-(4-hydroxy-3-phenethylcarbamoyl-phenoxy)-phenyl]-acetic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call